The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force (CITF).
Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response
December 1, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022